Clinical Trial: Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526545) titled 'Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial' on April 06.

Brief Summary: This clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection of prostate cancer. MPS2 is an investigational urine-based test designed to help identify the likelihood of having aggressive prostate cancer. MPS2 testing works by measuring specific early detection biomarkers that include genetic information. This next-generation test aims to address a major challenge in prostate cancer care-detec...